A next-in-class repurposed therapy for gout and similar inflammatory pain conditions, this candidate’s foundational technology features pairs of cationic and anionic peptides that co-assemble to form fibrillar structures. By varying peptide type, peptide concentration, or vehicle fabrication conditions, VivaMed can create nano-, micro-, or macro-scale vehicles to facilitate efficient delivery of anti-inflammatory APIs.